ID,MEDICATION,GENE(S),PRESCRIBING CONSIDERATIONS BASED ON myDNA TEST,INTERACTION
N83-352,Clopidogrel,CYP2C19,"Minor – result should be considered as may affect medicationresponse",NA
N83-352,Duloxetine (Cymbalta),"CYP1A2CYP2D6","Minor – result should be considered as may affect medicationresponse",INCREASED RISK OF SEROTONIN TOXICITY WITH ELETRIPTAN
N83-352,Celecoxib (Celebrex),CYP2C9,Usual prescribing considerations apply,NA
N83-352,Diclofenac,CYP2C9,Usual prescribing considerations apply,NA
N83-352,fluticasone,NA,NO,NA
N83-352, clonazepam,NA,NO,NA
N83-352, denosumab (Prolia),NA,NO,NA
N83-352, gabapentin,NA,NO,NA
N83-352, eletriptan,NA,NO,"INCREASED RISK OF SEROTONIN TOXICITY WITH DULOXETINE, INHIBITOR MODERATE: CYP2D6"
N83-352, salbutamol,NA,NO,NA
N83-352, amlodipine,NA,NO,NA
